Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

Author:

Vadivel Chella Krishna1ORCID,Willerslev-Olsen Andreas1ORCID,Namini Martin R. J.1ORCID,Zeng Ziao1ORCID,Yan Lang1,Danielsen Maria2ORCID,Gluud Maria1,Pallesen Emil M. H.1,Wojewoda Karolina3ORCID,Osmancevic Amra3ORCID,Hedebo Signe2ORCID,Chang Yun-Tsan4ORCID,Lindahl Lise M.2,Koralov Sergei B.5ORCID,Geskin Larisa J.6,Bates Susan E.7ORCID,Iversen Lars2,Litman Thomas1ORCID,Bech Rikke2,Wobser Marion8ORCID,Guenova Emmanuella4ORCID,Kamstrup Maria R.9ORCID,Ødum Niels1ORCID,Buus Terkild B.1ORCID

Affiliation:

1. 1LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

2. 2Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark

3. 3Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

4. 4Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland

5. 5Department of Pathology, New York University School of Medicine, New York, NY

6. 6Department of Dermatology, Columbia University Irving Medical Center, New York, NY

7. 7Division of Hematology/Oncology, Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY

8. 8Department of Dermatology, University Hospital Würzburg, Würzburg, Germany

9. 9Department of Dermatology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

Abstract

Abstract Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus–specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.

Publisher

American Society of Hematology

Reference89 articles.

1. Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant;Sézary;Bull Soc Fr Dermatol Syphiligr,1938

2. Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome;Brouet;N Engl J Med,1973

3. Cutaneous T cell lymphoma;Dummer;Nat Rev Dis Primers,2021

4. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders;Lutzner;Ann Intern Med,1975

5. The pathogenesis of mycosis fungoides;Girardi;N Engl J Med,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3